Injective (INJ) is currently trading at $2.89, reflecting a slight increase of 0.83% over the past 24 hours. The price movement remains confined within a daily range of $2.85 to $2.94, indicating a stable trading environment despite recent volatility.

The trading volume stands at approximately $46.87 million, representing a volume-to-market cap ratio of 16.20%, which suggests a healthy level of trading activity relative to its market capitalization. However, the 1-hour and 7-day RSI values of 44 and 45 indicate that INJ is approaching the oversold territory, suggesting potential downward pressure in the short term.

Technical indicators show mixed signals: the 8-day Simple Moving Average (SMA) is currently at $2.87 and trending upwards, while the longer-term 144-day SMA at $2.93 has a slight downtrend. Additionally, the recent price changes over the past 7, 14, and 30 days reflect a downward trend, with declines of approximately 5.76%, 12.26%, and 8.05% respectively, indicating bearish momentum.

Given that the price remains significantly below its all-time high of $52.62 reached in March 2024, there is considerable room for recovery. However, the consistent downward price movements and the current RSI metrics suggest that caution is warranted before making any aggressive trading decisions.

In conclusion, despite the potential for recovery, the current market conditions and technical indicators suggest a Hold rating for INJ. The mixed signals from both short and long-term metrics indicate that traders should monitor for signs of reversal before considering any positions.